BioRestorative Therapies (BRTX) 10-Q2013 Q1 Quarterly report

Filed: 15 May 13, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: agent, alenderin, ASU, bank, banker, Bermuda, borrowed, burning, caloric, certainlendersagreed, combined, constitute, conversion, coupon, credit, earlier, exposure, FASB, foregoing, glucose, guidance, human, imminent, implemented, ingredient, investigational, lipid, loan, negligible, open, placement, portion, President, principle, proposed, purpose, recognition, reduction, rendered, responsible, retroactive, retroactively, seeking, sell, sixteen, sundry, thinly, Topic, treated, Vice, waiver, website

Removed: achieve, administration, advanced, aggregating, approved, area, Argentina, arising, ASC, Asia, assistance, August, back, buttock, cardiac, case, center, CFO, clinical, closing, computation, computing, consultation, contemplated, culturing, dated, default, device, discretion, discretionary, discussing, disposition, dissolved, divided, employment, equipment, excellence, exclusive, facial, FDIC, feet, furnish, goal, hypertension, inactive, injection, investing, involve, involved, issue, January, leg, license, licensed, lieu, Lipo, lower, maintain, minimum, ninety, notice, obtained, October, optimization, ordinary, pain, past, patient, pay, pending, personal, position, potentially, predictable, private, procedure, provision, pursuing, ratio, regenerative, reimbursing, Rejuvenation, repaid, RS, shareholder, site, specific, spine, standard, sublicense, subsidiary, successive, technology, terminated, termination, threatened, tingling, training, tranche, ultimate, unity, utilize, web, weight, worldwide, written

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

BRTX similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350

Pursuant to 18 U.S.C. § 1350, the undersigned officer of BioRestorative Therapies, Inc. (the “Company”) hereby certifies that the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2013 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 15, 2013	/s/ Mark Weinreb
	Mark Weinreb
	Principal Executive and Financial Officer

The foregoing certification is being furnished solely pursuant to 18 U.S.C. § 1350 and is not being filed as part of the Report or as a separate disclosure document.